Trial Profile
Korean Study of "Real-World" Montelukast Use in Mild Asthmatic Children With Concomitant Allergic Rhinitis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 May 2022
Price :
$35
*
At a glance
- Drugs Montelukast (Primary) ; Corticosteroids
- Indications Allergic rhinitis; Asthma
- Focus Therapeutic Use
- Sponsors Merck Sharp & Dohme
- 16 Nov 2011 Trial phase changed from I to II as reported by ClinicalTrials.gov.
- 12 Nov 2008 Added Merck and Co secondary trial identifier MK0476-367, from ClinicalTrials.gov.
- 13 Feb 2008 Status changed from in progress to completed, as reported in ClinicalTrials.gov.